STAT+: White House taps Amazon, GoodRx, and Mark Cuban to bolster TrumpRx

STAT PlusBreaking News White House taps Amazon, GoodRx, and Mark Cuban to bolster TrumpRx Patients can now search for hundreds of generic medicines via TrumpRx Manage alerts for this article Email this article Share this article By Chelsea Cirruzzo and Daniel PayneMay 18, 2026 Chelsea Cirruzzo[email protected]Chelsea covers the Department of Health and Human Services with a particular focus on power and influence at the top. Confidential tips can be sent via Signal at chelseacirruzzo.42.Daniel Payne[email protected]Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of health care. Confidential tips can be sent on Signal at danielp.100. WASHINGTON — The White House announced an expansion of its prescription drug discount platform, TrumpRx, on Monday, adding more than 600 generic drugs to the website. The expansion comes via a partnership with entrepreneur Mark Cuban’s Cost Plus Drug Co, as well as Amazon Pharmacy and GoodRx, which each also provide drug savings or low cost prescription medicines.Advertisement “By incorporating this massive catalog of low-cost generics at TrumpRx.Gov, consumers will now have one source to ensure that they’re getting the lowest possible cost on their prescriptions,” President Trump said Monday at a White House event. “They have something that they’ve never had before.” STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%! 2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In CMS, Donald Trump, Drug prices, health tech, Policy, STAT+, White House Submit a correction requestReprints Chelsea Cirruzzo Washington Correspondent Chelsea covers the Department of Health and Human Services with a particular focus on power and influence at the top. Confidential tips can be sent via Signal at chelseacirruzzo.42. Daniel Payne Washington Correspondent Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of health care. Confidential tips can be sent on Signal at danielp.100. Newsletter The latest updates in federal health agencies, research institutes, and U.S. policy Recommended Health May 18, 2026 U.S. bans entry from Ebola-affected countries as American patient is identified Biotech May 18, 2026 STAT Plus: Supreme Court rejects challenge to Medicare drug price negotiation Advertisement Exclusive May 17, 2026 In Ebola outbreak, a number of Americans in the Congo believed to have had exposure to suspected cases Politics May 15, 2026 STAT Plus: FDA leadership shakeup widens following Makary’s departure Politics May 12, 2026 STAT Plus: Makary departs FDA amid turmoil as Diamantas, agency’s top food official, steps in Subscriber Picks